1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

US7683081B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Thorsten Blume · Schildow, DE
• Bernd Elger · Neustadt, DE
• Wolfgang Halfbrodt · Berlin, DE
• Joachim Kuhnke · Leverkusen, DE
• Ursula Moenning · Mölln, DE
• Herbert Schneider · Berlin, DE

Key dates

• Filing date: Aug 4, 2005
• Grant date: Mar 23, 2010
• Expiry date: May 3, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.